Oct 30, 2026 07:01AM
Oct 30, 2026 07:00AM
Oct 13, 2026 07:00AM
Oct 13, 2026 07:00AM
Sep 21, 2026 07:00AM
Sep 21, 2026 07:00AM
Aug 24, 2026 06:30PM Alkermes narcolepsy drug data published in The Lancet Neurology
Aug 24, 2026 06:30PM
Jul 13, 2026 07:01AM
Jul 13, 2026 07:00AM
Jun 17, 2026 04:15PM
Jun 17, 2026 04:15PM
Jun 15, 2026 07:02AM
Jun 15, 2026 07:00AM Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM
May 26, 2026 07:00AM
May 21, 2026 07:00AM
May 12, 2026 07:00AM
May 12, 2026 07:00AM
Apr 16, 2026 07:00AM Alkermes to present narcolepsy drug data at neurology meeting
Apr 16, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 24, 2026 08:52AM
Feb 25, 2026 06:55AM Alkermes names Blair Jackson as CEO to succeed Richard Pops in 2026
Feb 25, 2026 06:55AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 6, 2026 07:04AM
Jan 6, 2026 07:00AM
Nov 19, 2025 06:00AM
Nov 19, 2025 06:00AM Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
Nov 17, 2025 05:52AM
Nov 17, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 12, 2025 09:57AM
Oct 28, 2025 07:00AM
Oct 22, 2025 07:00AM Alkermes to acquire Avadel for up to $2.1 billion in cash deal
Oct 22, 2025 07:00AM
Sep 10, 2025 09:16AM
Jul 29, 2025 07:00AM
Jun 2, 2025 07:00AM
May 1, 2025 07:00AM
Feb 12, 2025 07:00AM
Jan 29, 2025 09:12AM Cantor Fitzgerald provides update on Biotechnology stocks
Jan 6, 2025 10:35AM

336,481 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All